PubMed HealthSearch

PubMed · 8234921

Recent developments in alcoholism:ethnicity.

Abstract

Advances in alcohol and ethnicity epidemiology during the past decade include greater emphasis on intraethnic variation, factors influencing drinking behavior, and building conceptual models. Despite progress, most research continues to focus on ethnicity/race as a demographic variable and few studies investigate ethnic hypotheses. Although prevention and treatment of alcoholic disorders in ethnic groups have been dealt with extensively in the clinical and ethnographic literature, little rigorous research has been conducted. The key issue in this area involves the extent to which prevention and treatment programming needs to be ethnically responsive in order to be effective. The very little empirical literature that exists on this topic suggests that answers will not be simple and will vary according to aspects of acculturation status and ethnohistorical factors. The most important development during the past 10 years has undoubtedly been the federal regulatory encouragement of research on the major ethnic groups of the United States.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H T Blane. 1993. Recent developments in alcoholism:ethnicity.. https://pubmed.ncbi.nlm.nih.gov/8234921/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit.

Excessive alcohol consumption is a major health and social issue in our society. Pharmacologic administration of the endocrine hormone fibroblast growth factor 21 (FGF21) suppresses alcohol consumption through actions in the brain in rodents, and genome-wide association studies have identified single nucleotide polymorphisms in genes involved with FGF21 signaling as being associated with increased alcohol consumption in humans. However, the neural circuit(s) through which FGF21 signals to suppress alcohol consumption are unknown, as are its effects on alcohol consumption in higher organisms. Here, we demonstrate that administration of an FGF21 analog to alcohol-preferring non-human primates reduces alcohol intake by 50%. Further, we reveal that FGF21 suppresses alcohol consumption through a projection-specific subpopulation of KLB-expressing neurons in the basolateral amygdala. Our results illustrate how FGF21 suppresses alcohol consumption through a specific population of neurons in the brain and demonstrate its therapeutic potential in non-human primate models of excessive alcohol consumption.

Alcohol Drinking

Induction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise.

The effects of both chronic ethanol consumption and repeated exercise on metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by rat lung microsomes were investigated. Keto aldehyde production was significantly enhanced 52% and 98%, respectively, by the ethanol and exercise, as was keto alcohol production (72% and 76%). 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) production was significantly enhanced only by the exercise (+32%). The combined treatment enhanced the keto alcohol production by 39%, indicating non-additive effects on cytochrome P450 (CYP) isozymes by the different treatments. Immunoblot and metabolic studies revealed an increased activity and content of CYP1A2 and CYP2B induced by the ethanol and exercise treatments as well as an induction of CYP2E1 proteins by the ethanol and combined treatments. These results indicate that both ethanol consumption and running exercise enhance NNK activation by increasing the expression of the CYP enzymes responsible for NNK activation.

Alcohol Drinking